Scinovex
reviewTop 1% cited

Circular RNA in cardiovascular disease

Journal of Cellular Physiology · 2018 · Vol. 234(5) · pp. 5588–5600
M‐Ashraf AlteshaTiffany NiAfaan KhanKexiang LiuXiufen Zheng

Abstract

Circular RNA (circRNA) are endogenous transcripts that display differential expression across species, developmental stages, and pathologies. Their lack of free ends confers increased stability when compared with linear transcripts, making them ideal candidates for future diagnostic biomarkers and therapeutic interventions. Increasing evidence has implicated circRNA in the pathogenesis of multiple cardiovascular diseases. In this paper, we summarize current understanding of circRNA biogenesis, properties, expression profiles, detection methods, functions, and their implication in cardiac pathologies including/ischemia reperfusion injury, myocardial infarction, cardiac senescence, cardiac fibrosis, cardiomyopathy, cardiac hypertrophy and heart failure, atherosclerosis, coronary artery disease, and aneurysm.

Circular RNAs in diseasesMicroRNA in disease regulationCancer-related molecular mechanisms researchCircular RNACoronary artery diseasePathogenesisDiseaseMedicineMyocardial infarctionCardiologyCardiomyopathyDiabetic cardiomyopathyFibrosis

MeSH terms

RNA, CircularAnimalsCardiovascular DiseasesCardiovascular SystemGene Expression RegulationHumansSignal Transduction

Funding

  • Natural Sciences and Engineering Research Council of Canada
Citations
528
FWCI
18.10
field-weighted impact
References
90
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.